Riichiroh Maruyama

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

Riichiroh Maruyama, Yutaka Nishiwaki, Tomohide Tamura et al. · Journal of Clinical Oncology · 2008 · 365 citations · Full text

Medicine, Oncology, Pharmacology +13

Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

Riichiroh Maruyama, Shinichi Toyooka, Kiyomi O. Toyooka et al. · PubMed · 2002 · 326 citations

Medicine, Oncology, Urology +17

Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer

Shinichi Toyooka, Riichiroh Maruyama, Kiyomi O. Toyooka et al. · International Journal of Cancer · 2002 · 289 citations · Full text

Medicine, Genetics, Oncology +17

DNA methylation profiles of lung tumors.

Shinichi Toyooka, Kiyomi O. Toyooka, Riichiroh Maruyama et al. · PubMed · 2001 · 231 citations

Life Sciences, Genetics, Oncology +17

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

Kenichi Harada, Shinichi Toyooka, Anirban Maitra et al. · Oncogene · 2002 · 226 citations

Medicine, Genetics, Oncology +17